抗精神病药物对精神分裂症患者体重的影响及护理对策

The influence of antipsychotics on body weight of schizophrenics and nursing countermeasures

分析抗精神病药物对精神分裂症患者体重的影响及护理对策。选择2017年6月—2018年6月我院收治的100例精神分裂症患者为研究对象,将其分为对照组、观察组,每组50例。两组患者均使用奥氮平治疗该疾病。对照组采用常规性护理,观察组采用针对性护理,分析其体重和护理结果。干预前,两组患者的体重指数无明显差异(P>0.05)。干预后,两组患者的体重指数均有增加趋势。从增加幅度来看,与对照组相比,观察组的体重指数增加幅度更小,组间数据差异有统计学意义(P>0.05)。对照组的护理满意度为86.00%,观察组的护理满意度为96.00%,与对照组相比,观察组的护理满意度更高(P<0.05)。使用奥氮平治疗该病会对患者的体重造成影响。在对精神分裂症患者治疗期间,应用针对性护理干预法,有助于减少患者体重上升的幅度,提升患者的护理满意度,促进疾病转归。

To analyze the effect of antipsychotics on weight of schizophrenic patients and nursing strategies, 100 patients with schizophrenia admitted to our hospital from June 2017 to June 2018 were selected as the research objects. They were divided into control group and observation group with 50 cases in each group. Both groups were treated with olanzapine. The control group was given routine nursing, while the observation group was given targeted nursing. The weight and nursing results were analyzed. Before intervention, there was no significant difference in BMI between two groups (P>0.05). After intervention, the body mass index of both groups increased. Compared with control group, the increase of body mass index in observation group was smaller, and there was significant difference between two groups (P>0.05). The nursing satisfaction of control group was 86.00%, and that of observation group was 96.00%. Compared with the control group, the nursing satisfaction of observation group was higher (P<0.05). The use of olanzapine in the treatment of the disease can affect the weight of patients. During the treatment of schizophrenic patients, the application of targeted nursing intervention can help reduce extent of weight gain, improve satisfaction of patients with nursing, and promote prognosis of the disease.